(Q41055142)

26 September 2017

1 reference

title

Multidrug resistance in acute myeloid leukaemia (English)

1 reference

26 September 2017

multiple drug resistance

1 reference

1 reference

Sonneveld P

1

1 reference

26 September 2017

1 March 1996

1 reference

Best Practice and Research: Clinical Haematology

26 September 2017

1 reference

26 September 2017

9

1 reference

26 September 2017

1

1 reference

26 September 2017

185-203

1 reference

Multidrug resistance and its circumvention

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Genetic mechanisms of drug resistance. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Correlation of MDR1 /P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Multidrug resistance-associated protein: sequence correction.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Detection of P glycoprotein activity on normal and leukemic CD34+ cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Reversal of drug-resistance in multiple myeloma with verapamil.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Expression of a multidrug resistance gene in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

ABC Transporters: From Microorganisms to Man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Glutathione-s-transferase pi expression in leukaemia: a comparative analysis with mdr-1 data

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

A pilot study of quinidine and epirubicin in the treatment of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

The effect of verapamil on the pharmacokinetics of adriamycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

The direct activation of human multidrug resistance gene (MDR1) by anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Multidrug resistance (mdr) genes in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Overexpression of the mdr1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

High-dose cytosine arabinoside: pharmacological and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

MDR1 gene expression and treatment outcome in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Expression of the multidrug resistance gene in myeloid leukemias.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Modulation of multidrug resistance: at the threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Cyclosporins as drug resistance modifiers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Comparative effects of racemic verapamil vs R-verapamil on normal and leukemic progenitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

Cytosine arabinoside influx and nucleoside transport sites in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980043-6

7 January 2021

10.1016/S0950-3536(96)80043-6

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

8730557